How much do the public sector and the private sector contribute to biopharmaceutical R&D?

Prof. Steven Simoens is a senior full professor of health economics at KU Leuven. Steven carries out cost(-of-illness) analyses, economic evaluations and budget impact analyses for medicinal products. He is also interested in pharmaceutical market access, with a particular focus on oncology medicines, orphan medicines, generic and biosimilar medicines, vaccines, and cell and gene therapies.

Prof. Isabelle Huys is full professor at KU Leuven and specializes in intellectual property rights and regulatory sciences. Her research interests focus on legal and regulatory strategies for medicine development, (human) biological samples and related therapies and diagnostics, as certain therapies remain unavailable to patients due to legal or regulatory barriers. https://www.kuleuven.be/wieiswie/en/person/00031958

© 2021 Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif